email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1201 - 1215
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Qiming Launches $500 Million Fund to Invest in Listed Healthcare Companies
$5.00
Available
Qiming Launches $500 Million Fund to Invest in Listed Healthcare Companies
$5.00
Available
Qiming Launches $500 Million Fund to Invest in Listed Healthcare Companies
$5.00
Available
ProfoundBio Makes $246 Million Deal for Synaffix Linker-Payload Technology
$5.00
Available
Antengene to Start Trial of PD-L1/4-1BB Bispecific in Solid Tumors and NHL
$5.00
Available
Mabworks Plans Hong Kong IPO to Support Antibody/Multi-Specifics Pipeline
$5.00
Available
Qilu Pharma Starts China Bridging Trial for Bladder Cancer Drug
$5.00
Available
Junshi Forms $16 Million mRNA JV with Hangzhou's Immorna
$5.00
Available
GenFleet Partners with Insilico for AI-based Drug Discovery
$5.00
Available
Eluminex Acquires Synthetic Cornea Product in $108 Million Agreement
$5.00
Available
Juventas Closes $62 Million C Round for CAR-T/Stem Cells/Gene Editing
$5.00
Available
Frontier Says HIV Therapy Effective in Difficult-to-Treat Patients
$5.00
Available
Hailai Xinchuang Closes $77 Million Round for Tumor Treating Fields Device
$5.00
Available
Grit Bio Closes Series A+ Round for its Cell Therapy Oncology Therapies
$5.00
Available
Innovent and Ascentage Announce Three-Part, $245 Million Collaboration
$5.00
Available